1. Home
  2. ESTA vs HTFL Comparison

ESTA vs HTFL Comparison

Compare ESTA & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Establishment Labs Holdings Inc.

ESTA

Establishment Labs Holdings Inc.

HOLD

Current Price

$93.11

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Heartflow Inc.

HTFL

Heartflow Inc.

HOLD

Current Price

$24.15

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESTA
HTFL
Founded
2004
2007
Country
United States
United States
Employees
N/A
843
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ESTA
HTFL
Price
$93.11
$24.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$86.86
$38.20
AVG Volume (30 Days)
682.5K
1.9M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
42.67
N/A
EPS
N/A
N/A
Revenue
$61,208,000.00
N/A
Revenue This Year
$28.05
$27.66
Revenue Next Year
$26.21
$23.55
P/E Ratio
N/A
N/A
Revenue Growth
76.49
N/A
52 Week Low
$33.35
$20.13
52 Week High
$96.99
$41.22

Technical Indicators

Market Signals
Indicator
ESTA
HTFL
Relative Strength Index (RSI) 60.16 37.67
Support Level $63.71 $20.27
Resistance Level $92.84 $25.05
Average True Range (ATR) 3.57 1.60
MACD -0.25 -0.27
Stochastic Oscillator 66.63 9.26

Price Performance

Historical Comparison
ESTA
HTFL

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Share on Social Networks: